Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy

Part of paid clinical trials in Newark, Delaware.

Sponsor
Christiana Care Health Services
Study ID
NCT07664956
Phase
PHASE4
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Abnormal Uterine Bleeding, Unspecified
  • Adenomyosis of Uterus
  • Adnexal Diseases
  • Chronic Pelvic Pain
  • Endometriosis
  • Endometritis
  • Fibroid Uterus
  • Menorrhagia
  • Minimally Invasive Surgical Procedures

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Cyclobenzaprine — DRUG
    5mg cyclobenzaprine q8hr for one week postoperatively after minimally invasive hysterectomy

Study Details

Typical postoperative pain control after minimally invasive hysterectomy includes ibuprofen, acetaminophen, and a short course of narcotics. The purpose of this study is to see if adding cyclobenzaprine to this regime improves pain control and lessens narcotic use.

Key Dates

Start date
Jul 1, 2026
Status verified
Jun 2026
Primary completion
Sep 1, 2026
Completion
Dec 1, 2026

Study Design

Enrollment
36 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • No Intervention: Control
    No additional intervention
  • Experimental: Cyclobenzaprine
    5mg cyclobenzaprine q8h for one week postoperatively

Primary Outcome Measure

Visual Analog Scale (VAS) Pain Score on Post Op Day 3 [ Time Frame: 3 days postoperatively ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
ChristianaCare Health SystemNewarkDelaware19718-

Find similar trials in Newark, DE

By condition

Related Studies